Clinical Cancer Research · 2011 · 119 citations · 17 references
MedicineOncologyPathologyMolecular DiagnosticsMolecular OncologyProteomicsBiomarker ValidationBiomarkers In PathologyCancer BiomarkersImmuno-oncology BiomarkersMolecular Tumor ProfilingTumor MarkersBiomarkers Of Cancer RiskDiagnostic SensitivityDisease Stage AssessmentLung Cancer RiskMolecular Biomarker ValidationProtein Biomarker ValidationSensitivityTumor Biomarker Discovery
PURPOSE: Our objective was to validate the performance of three new candidate lung cancer biomarkers, pentraxin-3 (PTX3), human kallikrein 11 (KLK11), and progranulin. EXPERIMENTAL DESIGN: We analyzed by commercial ELISA, and with a blinded protocol, 422 samples from 203 patients with lung carcinoma, 180 individuals with high risk for lung cancer (heavy smokers), and 43 individuals with cancers other than lung. All samples were obtained from the Early Detection Research Network (Reference set A). RESULTS: We found that progranulin and KLK11 were not informative lung cancer biomarkers, with areas under the receiver operating characteristic curve (AUC; ROC), close to 0.50. However, PTX3 was an informative lung cancer biomarker, with considerable ability to separate lung cancer patients from high-risk controls. At 90% and 80% specificity, the sensitivities versus the high-risk control group were 37% and 48%, respectively. The discriminatory ability of PTX3 was about the same with all major subtypes and histotypes of lung cancer. The AUC of the ROC curves increased according to the disease stage, from 0.64 (stage I) to 0.72 (stage IV). CONCLUSION: PTX3, but not KLK11 or progranulin, is a new serum biomarker for lung carcinoma. Its diagnostic sensitivity and specificity is similar to other clinically used lung cancer biomarkers. More studies are needed to establish if PTX3 has clinical utility for lung cancer diagnosis and management.
17
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text
Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera
Ji Qiu, Gina Choi, Lin Z. Li et al. · Journal of Clinical Oncology · 2008 · 192 citations · Full text
Life Sciences, Immunology, Oncology +17
Girish Sardana, Klaus Jung, Carsten Stephan et al. · Journal of Proteome Research · 2008 · 162 citations
Medicine, Biochemistry, Oncology +17